Dudediligence.

Evommune, Inc

EVMNNYSE · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,548,621

6 notices · 111,556 sh

Oct 2025 to Oct 2026

Reported ·

$2,279,118

9 sales · 5 buys · $70.0M bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 9 reported sales carry the 10b5-1 box. Together they are 0.28% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-22: JANICE DREW, Form 1442026-06-02: DAVID COHEN, Form 1442026-06-01: LUIS PENA, Form 1442026-06-01: JEEGAR PATEL, Form 1442026-05-28: GREGORY MOSS, Form 1442026-05-28: KYLE CARVER, Form 1442025-11-07: RA CAPITAL MANAGEMENT, L.P., bought2025-11-07: LSP 7 Cooperative UA, bought2025-11-07: Verduyn-van Weegen Felice Isabel, bought2025-12-19: Hopfner Robert Lorne, bought2026-05-28: Moss Gregory S., sold2026-05-28: Carver Kyle, sold2026-06-01: Pena Luis C., sold2026-06-01: Patel Jeegar Pravinkumar, sold2026-06-02: Cohen David E, sold2026-06-22: Pena Luis C., sold2026-06-22: Drew Janice Suzann, sold2026-06-22: Patel Jeegar Pravinkumar, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-06-22JANICE DREW, Chief of Dev. Operations$427,200
20,000 shplan 2026-03-09144 ↗
Form 4, 2026-06-24: sold 20,000 at $22.63 Form 4 ↗
2026-06-02DAVID COHEN, Director$205,250
9,258 shplan 2026-03-03144 ↗
Form 4, 2026-06-03: sold 6,056 at $20.33 Form 4 ↗
2026-06-01LUIS PENA, President & CEO$562,747
24,225 shplan 2026-03-02144 ↗
Form 4, 2026-06-03: sold 16,787 at $22.74 Form 4 ↗
2026-06-01JEEGAR PATEL, Chief Scientific Officer$422,205
18,175 shplan 2026-02-27144 ↗
Form 4, 2026-06-03: sold 16,687 at $22.74 Form 4 ↗
2026-05-28GREGORY MOSS, Chief Business & Legal Officer$331,965
14,223 shplan 2026-02-26144 ↗
Form 4, 2026-06-01: sold 14,223 at $22.83 Form 4 ↗
2026-05-28KYLE CARVER, Chief Financial Officer$599,255
25,675 shplan 2026-02-26144 ↗
Form 4, 2026-06-01: sold 18,175 at $22.84 Form 4 ↗